The phosphatase Cdc25A plays an important role in cell cycle regulation by
removing inhibitory phosphates from tyrosine and threonine residues of cycl
in-dependent kinases, and it has been shown to transform diploid murine fib
roblasts in cooperation with activated Ras. Here we show that Cdc25A is ove
rexpressed in primary breast tumors and that such overexpression is correla
ted with higher levels of cyclin-dependent kinase 2 (Cdk2) enzymatic activi
ty in vivo. Furthermore, in the breast cancer cell line MCF-7, Cdc25A activ
ity is necessary for both the activation of Cdk2 and the subsequent inducti
on of S-phase entry. Finally, in a series of small (< 1 cm) breast carcinom
as, overexpression of Cdc25A was found in 47% of patients and was associate
d with poor survival. These data suggest that overexpression of Cdc25A cont
ributes to the biological behavior of primary breast tumors and that both C
dc25A and Cdk2 are suitable therapeutic targets in early-stage breast cance
r.